The negative impact of COVID-19 pandemic on age-related macular degeneration patients treated with intravitreal bevacizumab injections.
Roee ArnonJoseph PikkelTal YahalomiNir StanescuKeren WoodAri LeshnoAsaf AchironAssaf HilelyPublished in: International ophthalmology (2022)
The findings demonstrate the negative implications of the COVID-19 pandemic and the effect of deferring bevacizumab injections among individuals with age-related macular degeneration. This emphasizes the importance of a scheduled follow-up, also during a pandemic.